Kuros Biosciences Announces Three Advancements Related to it

Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA

Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Zurich , Züsz , Switzerland , Netherlands , United States , Utrecht , Swiss , Van Dijk , Moyo Kruijt , Kuros Biosciences , Data Research , University Medical Centre Utrecht , Swiss Exchange , Drug Administration , Biosciences Announces Three Advancements Related , Including Impressive Fusion Data , Randomized Clinical Trial , Preliminary Results , Magnetos Easypack Putty , Magnetos Putty , Orthopedic Spine Surgeon , Chief Executive Officer , Sci Advisors , Daniel Geiger , Chief Financial Officer , Investor Relations , Magnetos , Statement Magnetos Easypack Putty , Looking Statements This , How Many Spinal Fusions , Performed Each Year , Biomed Mater , Dow Jones Newswires ,